Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Paused · Phase 2

Conditions studied: HIV Infections

In brief

The purpose of this study is to look at the effectiveness of giving a new anti-HIV drug (AG1549) plus Viracept (nelfinavir) plus Combivir (a tablet containing zidovudine plus lamivudine) to HIV-infected patients who are not taking anti-HIV drugs.

Key facts

Study ID

NCT00004999

Run by

Agouron Pharmaceuticals

People needed

350

Starts

1999-08-01

Last updated by the study team

2005-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients may be eligible if they:
• Are HIV-positive.
• Are at least 18 years old.
• Have a CD4 cell count of more than 50 cells/mm3.
• Have an HIV level of more than 5000 copies/ml.

You may not qualify if…

• Patients will not be eligible if they:
• Have ever taken any of the following anti-HIV drugs: nonnucleoside reverse transcriptase inhibitors (NNRTIs), AG1549, Viracept, zidovudine, lamivudine, or Combivir. Other anti-HIV drugs are allowed only if taken for no more than 30 days with the last dose taken more than 6 months prior to study entry.
• Have taken an experimental drug within 28 days of study entry.

Where it is running

• Univ of Southern California — Los Angeles, California, United States
• Highland Gen Hosp / San Francisco Gen Hosp — Oakland, California, United States
• ViRx Inc — Palm Springs, California, United States
• Research & Treatment at the California Pacific Med Ctr — San Francisco, California, United States
• Harbor - UCLA Med Ctr — Torrance, California, United States
• IDC Research Initiative — Altamonte Springs, Florida, United States
• Bach and Godofsky — Bradenton, Florida, United States
• Community Health Care — Fort Lauderdale, Florida, United States
• Univ of Florida — Jacksonville, Florida, United States
• Univ of Miami School of Medicine — Miami, Florida, United States
• South Shore Hosp — Miami, Florida, United States
• Specialty Med Care Ctrs of South Florida Inc — Miami, Florida, United States
• Orange County Health Dept — Orlando, Florida, United States
• Larry Bush — Palm Springs, Florida, United States
• Infectious Diseases Associates — Sarasota, Florida, United States
• Infectious Disease Research Institute — Tampa, Florida, United States
• Treasure Coast Infectious Disease Consultants — Vero Beach, Florida, United States
• Polk County Health Dept — Winter Haven, Florida, United States
• Sky Blue — Boise, Idaho, United States
• Northwestern Univ Med Ctr — Chicago, Illinois, United States
• The CORE Ctr — Chicago, Illinois, United States
• Indiana Univ Infectious Disease Research Clinic — Indianapolis, Indiana, United States
• Univ of Iowa — Iowa City, Iowa, United States
• Univ of Kansas School of Medicine — Wichita, Kansas, United States
• Arizona Clinical Research Ctr Inc — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.